Skip to main content
See Dr. Mor’s Publications

Eliran Mor, MD

Reproductive Endocrinologist located in Encino, Santa Monica, Valencia & West Hollywood, CA

Reproductive Endocrinologist located in Encino, Valencia & West Hollywood, CA

Doctor Mor received his medical degree from Tel Aviv University-Sackler School of Medicine in Israel. He completed a four-year residency in Obstetrics and Gynecology at New York Methodist Hospital in Brooklyn, New York. Subsequently, Dr. Mor completed a three-year fellowship in Reproductive Endocrinology and Infertility at the University of Southern California. Doctor Mor is Board Certified in both Reproductive Endocrinology/Infertility and Obstetrics and Gynecology. Throughout his career Dr. Mor has researched many topics in infertility and human reproduction, including polycystic ovary syndrome (PCOS); emergency contraception; neuroendocrinology; insulin resistance; male factor infertility; donor sperm insemination; tubal factor infertility; IVF stimulation protocols; congenital uterine anomalies; tubal gamete/embryo transfer (GIFT/ZIFT/TET); pregnancy at advanced reproductive age; and hormone replacement therapy (HRT), and continues to do so today. He is a member, in excellent standing, of multiple prestigious medical societies, including the American Society of Reproductive Medicine (ASRM), the Pacific Coast Reproductive Society (PCRS), the Society of Laparoendoscopic Surgeons (SLS), and the American College of Obstetricians and Gynecologists (ACOG), and remains a Clinical Instructor at USC.

Doctor Mor is one fertility expert who is constantly striving to stay on the cutting-edge of fertility treatments and human reproduction. In addition to monthly Journal Club meetings/publication review sessions and educational seminars/lectures, Dr. Mor attends at least two major Reproductive Endocrinology/Infertility meetings each year in an effort to present his patients with the latest in innovative reproductive care. Only interventions that have been tested and validated through multiple good studies are adopted in Dr. Mor’s practice, in an effort to administer safe and effective treatments to achieve a healthy pregnancy.

A true “patients’ doctor,” Dr. Mor is and will be your physician throughout your fertility journey! All consultations, after-hour inquiries, pelvic examinations, ultrasound examinations, diagnostic procedures, assisted reproductive procedures (egg retrievals, embryo transfers…), and surgical procedures, if needed, will be performed by Dr. Mor. Involvement in every aspect of your fertility care and complete micromanagement of your treatment makes Dr. Mor your ideal partner in your path to becoming pregnant.

Peer-Review Journals:

  1. Chang PL, Mor E, Sauer MV. Evaluating the clinical utility of performing semen cultures prior to attempts at in-vitro fertilization. J Assist Reprod Rev 1997;7:181-7.
  2. Mor E, Lindheim SR, Lerner J, Sauer MV. Combined intrauterine, tubal, and cervical pregnancies following in vitro fertilization and embryo transfer. J Assist Reprod Genet 2001;18:349-51.
  3. Mor E, Saadat P, Sokol RZ, Paulson RJ. Spontaneous twin gestation after vaginal dilation in a woman with uterus didelphys and bladder exstrophy. Obstet Gynecol 2002;100:1138-41.
  4. Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC, Francis MM, Jain JK. Pregnancy in the sixth decade of life: Obstetrical outcomes in women of advanced reproductive age. JAMA 2002;288:2320-3.
  5. Mor E, Zograbyan A, Saadat P, Bayrak A, Tourgeman DE, Zhang C, Stanczyk FZ, Paulson RJ. The insulin resistant sub-phenotype of polycystic ovary syndrome: Clinical parameters and pathogenesis. Am J Obstet Gynecol 2004;190(6):1654-1660.
  6. Mor E, Bayrak A, Saadat P, Tourgeman DE, Jain JK, Sokol RZ, Paulson RJ. Gonadotroph adenoma and resulting ovarian hyperstimulation: A report of three cases. Fertil Steril 2005;84(3)757.
  7. Mor E, Saadat P, Kives Z, Zhang X, Kacina A, Reid RL, Paulson RJ, Stanczyk FZ. Comparison of vaginal and oral administration of emergency contraception. Fertil Steril 2005;84(1):40-45.
  8. Mor E, Saadat P, Zhang C, Stanczyk FZ, Slater CC, Paulson RJ. Serum androgen levels in controlled ovarian hyperstimulation cycles utilizing gonadotropin-releasing hormone antagonists or agonists. Fertil Steril, submitted.
  9. Mor E, Landay M, Paulson RJ. Endometrial receptivity is preserved in Diethystilbestrol-associated and other Mu”llerian anomalies: Evidence from tubal embryo transfer. J Assist Reprod Genet 2009;26(1):65-68
  10. Bayrak A, Saadat P, Mor E, Chong L, Paulson RJ, Sokol RZ. Pituitary imaging is indicated for the evaluation of hyperprolactinemia. Fertil Steril 2005;84(1):181-185.
  11. Bayrak A, Harp D, Saadat P, Mor E, Paulson RJ. Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population. J Assist Repro Gen 2006;1:1-4.
  12. Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ. Acute effects of Metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril 2007;87(4):870-875.

Abstracts:

  1. Mor E, Saadat P, Kacina A, Kives S, Zhang X, Paulson RJ, Stanczyk FZ, Reid RL. Alterations in hepatic proteins following oral and vaginal administration of the Yuzpe regimen and plan B for emergency contraception. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20-23, 2002, Los Angeles, California.
  2. Saadat P, Mor E, Kives S, Zhang X, Paulson RJ, Stanczyk FZ, Reid RL. Alterations in circulating androgen levels following oral and vaginal administration of the Yuzpe regimen and plan B for emergency contraception. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20-23, 2002, Los Angeles, California.
  3. Mor E, Saadat P, Kives S, Zhang C, Paulson RJ, Reid R, Stanczyk FZ. Alterations in gonadotropin levels following oral and vaginal administration of the Yuze regimen and plan B for emergency contraception. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.
  4. Saadat P, Boostanfar R, Mor E, Zhang C, Paulson RJ, Roy S, Stanczyk FZ. Effects of oral and transdermal hormone replacement therapy on serum free testosterone levels in postmenopausal women. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.
  5. Saadat P, Mor E, Slater CC, Stanczyk FZ, Paulson RJ, Shoupe D, Hodis HN, Mack WJ. Postmenopausal oral estrogen replacement therapy and changes in blood pressure: A randomized placebo-controlled trial. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.
  6. Mor E, Saadat P, Zhang C, Stanczyk FZ, Slater CC, Jain J, Tourgeman D, Paulson RJ. Ovarian and adrenal androgen profiles in cycles of controlled ovarian hyperstimulation utilizing GnRH antagonists or agonists. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17-21, 2002, Rancho Mirage, California.
  7. Mor E, Boostanfar R, Saadat P, Tourgeman DE, Slater CC, Paulson RJ. Pregnancy outcome at the upper extreme of reproductive age: A comparison of two recipient groups. Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, October 12-17, 2002, Seattle, Washington.
  8. Saadat P, Aliabadi T, Tourgeman DE, Mor E, Slater CC, Paulson RJ. The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tubo-peritoneal disease. Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, October 12-17, 2002, Seattle, Washington.
  9. Mor E, Saadat P, Bayrak A, Tourgeman DE, Jain JK, Francis MM, Paulson RJ. Pregnancy outcome in advanced reproductive age: A comparison between egg donation recipients and fertile women over 40 years of age. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, March 26-30, 2003, Washington, DC.
  10. Saadat P, Saadat P, Zhang C, Chang L, Zafarian N, Mor E, Stanczyk FZ, Paulson RJ. Efficacy and reliability of commercially available direct chemiluminescent immunoassays and radioimmunoassays in predicting serum progesterone values: Should these assays be used in clinical practice? Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, March 26-30, 2003, Washington, DC.
  11. Mor E, Saadat P, Bayrak A, Sokol RZ, Jain JK, Tourgeman DE, Paulson RJ. Insulin resistance in polycystic ovary ovarian syndrome: Impact on ovulation and common clinical and metabolic parameters. Presented at the 51st Annual Meeting of the Pacific Coast Reproductive Society, April 23-27, 2003, Rancho Mirage, California.
  12. Bayrak A, Saadat P, Mor E, Urwitz-Lane R, Chong L, Paulson RJ, Sokol RZ. Hyperprolactinemia: Guidelines for clinical assessment and pituitary imaging. Presented at the 51st Annual Meeting of Pacific Coast Reproductive Society, April 23-27, 2003, Rancho Mirage, California. (PCRS Prize Paper to be presented at the 2003 Annual Meeting of the European Society of Human Reproduction and Embryology).
  13. Bayrak A, Saadat P, Mor E, Urwitz-Lane R, Chong L, Paulson RJ, Sokol RZ. Hyperprolactinemia: Guidelines for clinical assessment and pituitary imaging. Presented at the 19th Annual Meeting of the European Society of Human Reproduction and Embryology, June 29, 2003 – July 2, 2003, Madrid, Spain.
  14. Zograbyan A, Mor E, Zhang C, Saadat P, Bayrak A, Sokol RZ, Jain JK, Tourgeman DE, Stanczyk FZ, Paulson RJ. Insulin resistance in polycystic ovary syndrome: Clinical implications of fasting glucose and insulin levels. Presented at the 70th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16-21, 2003, Anchorage, Alaska. (Frank Lynch Memorial Essay Award).
  15. Almassi M, Saadat P, Mor E, Chang L, Talwalker S, Ji Q, Paulson RJ, Stolz A, Stanczyk FZ. Idiopathic hirsutism: Is 5a-reductase the only pivotal enzyme? Presented at the 70th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16-21, 2003, Anchorage, Alaska.
  16. Mor E, Zograbyan A, Zhang C, Bayrak A, Stanczyk FZ, Paulson RJ. Defective autophosphorylation of the insulin receptor (APIR): A potential mechanism of insulin resistance in polycystic ovary syndrome (PCOS). Presented at the 59th Annual Meeting of the American Society for Reproductive Medicine, October 11-15, 2003, San Antonio, Texas. (Society for Reproductive Endocrinology and Infertility Fellowship Research Prize Paper Award).
  17. Bayrak A, Harp D, Saadat P, Mor E, Paulson RJ. Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population. Presented at the 59th Annual Meeting of the American Society for Reproductive Medicine, October 11-15, 2003, San Antonio, Texas.
  18. Mor E, Chaikittisilpa S, Stancyzk FZ, Paulson RJ, Pike MC, Wu AH. Effect of soy and low-fat diet on circulating insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 in postmenopausal women: A prospective randomized trial. Presented at the 51st Annual Meeting of the Society for Gynecologic Investigation, March 24-27, 2004, Houston, Texas.
  19. Chaikittisilpa S, Mor E, Stanczyk FZ, Paulson RJ, Pike MC, Wu AH. Effects of soy and very low-fat diet on serum insulin and leptin levels in healthy postmenopausal women: A prospective randomized trial. Presented at the 51st Annual Meeting of the Society for Gynecologic Investigation, March 24-27, 2004, Houston, Texas.
  20. Voxman EG, Saadat P, Mor E, Guberman C, Kovacs BW, Stanczyk FZ. Cord blood leptin and insulin levels: Association with gender, birth weight, and placental weight. Presented at the 51st Annual Meeting of the Society for Gynecologic Investigation, March 24-27, 2004, Houston, Texas.
  21. Mor E, Urwitz-Lane R, Bayrak A, Stanczyk FZ, Paulson RJ. Acute effect of low dose metformin treatment on insulin resistance and hyperandrogenemia in insulin resistant women with polycystic ovary syndrome (PCOS). Presented at the 52nd Annual Meeting of Pacific Coast Reproductive Society, April 28, 2004 – May 2, 2004, Rancho Mirage, California.
  22. Mor E, Bayrak A, Tourgeman DE, Jain JK, Paulson RJ. Embryo implantation in women with Mu”llerian anomalies: Role of tubal embryo transfer. Presented at the 52nd Annual Meeting of Pacific Coast Reproductive Society, April 28, 2004 – May 2, 2004, Rancho Mirage, California.
  23. Bayrak A, Kalan M, Steiner A, Mor E, Paulson RJ, Sokol RZ. Effectiveness of bromocriptine therapy in hyperprolactinemic patients with or without pituitary tumor. Presented at the 60th Annual Meeting of the American Society for Reproductive Medicine, October 2005, Philadelphia, Pennsylvania.
  24. Ghadir S, Huang A, Mor E, DeCherney AH, Buyalos RP, Durinzi KL. Therapeutic donor insemination in advanced reproductive aged women: impact of cycle type on success. Presented at the 60th Annual Meeting of the American Society for Reproductive Medicine, October 2005, Philadelphia, Pennsylvania.
  25. Mor E, Vermesh M. Combined gamete or zygote intrafallopian transfer (GIFT or ZIFT) and in vitro fertilization-embryo transfer (IVF-ET) in women with prior failed cycles: significantly improved success rates compared with GIFT or ZIFT alone. Presented at the 53rd Annual Meeting of the Pacific Reproductive Society, May 2005, Indian Wells, California.
  26. Ghadir S, Mor E, Azziz R. Hyperandrogenic insulin resistant acanthosis nigricans (HAIRAN) syndrome: treatment of hyperandrogenic symptoms with combined oral contraceptives (OCs) and spironolactone (SPA). Presneted at the 87th Annual Meeting of the Endocrine Society, 2005, San Diego, California.
  27. Mor E, Vermesh M. Combined Gamete Intrafallopian Transfer (GIFT)/In Vitro Fertilization-Embryo Transfer (IVF-ET) versus Zygote Intrafallopian Transfer (ZIFT)/IVF-ET in Women with Prior Failed IVF. Presented at the 54th Annual Meeting of the Pacific Reproductive Society, April 2006, Indian Wells, CA.
  28. Mor E, Vermesh M. Combined gamete or zygote intrafallopian transfer (GIFT or ZIFT) and in vitro fertilization-embryo transfer (IVF-ET) in women with prior failed cycles: significantly improved success rates over IVF alone. Presented at the 61st Annual Meeting of the American Society for Reproductive Medicine, October 2006, New Orleans, Louisiana.